352 related articles for article (PubMed ID: 15496640)
1. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.
Levy RH; Ragueneau-Majlessi I; Garnett WR; Schmerler M; Rosenfeld W; Shah J; Pan WJ
J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS
Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127
[TBL] [Abstract][Full Text] [Related]
3. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy.
Ragueneau-Majlessi I; Levy RH; Brodie M; Smith D; Shah J; Grundy JS
Clin Pharmacokinet; 2005; 44(5):517-23. PubMed ID: 15871637
[TBL] [Abstract][Full Text] [Related]
4. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
5. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy.
Pattanaik S; Hota D; Prabhakar S; Kharbanda P; Pandhi P
Phytother Res; 2006 Aug; 20(8):683-6. PubMed ID: 16767797
[TBL] [Abstract][Full Text] [Related]
6. Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects.
Spaans E; van den Heuvel MW; Schnabel PG; Peeters PA; Chin-Kon-Sung UG; Colbers EP; Sitsen JM
Eur J Clin Pharmacol; 2002 Sep; 58(6):423-9. PubMed ID: 12242602
[TBL] [Abstract][Full Text] [Related]
7. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
8. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
9. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
[TBL] [Abstract][Full Text] [Related]
10. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
11. Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy.
Levy RH; Ragueneau-Majlessi I; Brodie MJ; Smith DF; Shah J; Pan WJ
Ther Drug Monit; 2005 Apr; 27(2):193-8. PubMed ID: 15795651
[TBL] [Abstract][Full Text] [Related]
12. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy.
Wallander KM; Ohman I; Dahlin M
Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs.
Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M
J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148
[TBL] [Abstract][Full Text] [Related]
14. Zonisamide monotherapy for epilepsy in children and young adults.
Wilfong AA
Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and drug interactions with zonisamide.
Sills G; Brodie M
Epilepsia; 2007 Mar; 48(3):435-41. PubMed ID: 17319920
[TBL] [Abstract][Full Text] [Related]
16. Effect of zonisamide on serum immunoglobulins.
Fujimoto Y; Ikoma R; Shimizu T; Shimizu A
Arzneimittelforschung; 1990 Aug; 40(8):855-8. PubMed ID: 2242076
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
Baulac M; Leppik IE
Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and toxicity of zonisamide in cats.
Hasegawa D; Kobayashi M; Kuwabara T; Ohmura T; Fujita M; Orima H
J Feline Med Surg; 2008 Aug; 10(4):418-21. PubMed ID: 18372205
[TBL] [Abstract][Full Text] [Related]
19. A long-term follow-up of zonisamide monotherapy.
Fukushima K; Seino M
Epilepsia; 2006 Nov; 47(11):1860-4. PubMed ID: 17116025
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
Tosches WA; Tisdell J
Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
